Literature DB >> 18398019

PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.

Andreas Pasch1, Felix J Frey, Ute Eisenberger, Markus G Mohaupt, Olivier Bonny.   

Abstract

BACKGROUND: Renal calcium stones and hypercalciuria are associated with a reduced bone mineral density (BMD). Therefore, the effect of changes in calcium homeostasis is of interest for both stones and bones. We hypothesized that the response of calciuria, parathyroid hormone (PTH) and 1.25 vitamin D to changes in dietary calcium might be related to BMD.
METHODS: A single-centre prospective interventional study of 94 hyper- and non-hypercalciuric calcium stone formers consecutively retrieved from our stone clinic. The patients were investigated on a free-choice diet, a low-calcium diet, while fasting and after an oral calcium load. Patient groups were defined according to lumbar BMD (z-score) obtained by dual X-ray absorptiometry (group 1: z-score <-0.5, n = 30; group 2: z-score -0.5-0.5, n = 36; group 3: z-score >0.5, n = 28). The effect of the dietary interventions on calciuria, 1.25 vitamin D and PTH in relation to BMD was measured.
RESULTS: An inverse relationship between BMD and calciuria was observed on all four calcium intakes (P = 0.009). On a free-choice diet, 1.25 vitamin D and PTH levels were identical in the three patient groups. However, the relative responses of 1.25 vitamin D and PTH to the low-calcium diet were opposite in the three groups with the highest increase of 1.25 vitamin D in group 1 and the lowest in group 3, whereas PTH increase was most pronounced in group 3 and least in group 1.
CONCLUSION: Calcium stone formers with a low lumbar BMD exhibit a blunted response of PTH release and an apparently overshooting production of 1.25 vitamin D following a low-calcium diet.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398019     DOI: 10.1093/ndt/gfn091

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

2.  Relationship between Urinary Calcium and Bone Mineral Density in Patients with Calcium Nephrolithiasis.

Authors:  Khashayar Sakhaee; Naim M Maalouf; John Poindexter; Beverley Adams-Huet; Orson W Moe
Journal:  J Urol       Date:  2017-01-05       Impact factor: 7.450

3.  Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.

Authors:  Emmanuel Letavernier; Olivier Traxer; Michel Daudon; Mohammed Tligui; Jérôme Hubert-Brierre; Dominique Guerrot; Aline Sebag; Laurent Baud; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

Review 4.  Nephrolithiasis-associated bone disease: pathogenesis and treatment options.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Rajiv Kumar; Andreas Pasch; Orson W Moe
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

5.  UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.

Authors:  Naeem Bhojani; Jennifer Bjazevic; Brendan Wallace; Linda Lee; Kamaljot S Kaler; Marie Dion; Andrea Cowan; Nabil Sultan; Ben H Chew; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

6.  A genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis.

Authors:  Yii-Her Chou; Peng Yeong Woon; Wei-Chiao Chen; Yu-Wen Hsu; Jer-Ming Chang; Daw-Yang Hwang; Yi-Ching Chiu; Ho-Chang Kuo; Wei-Pin Chang; Ming-Feng Hou; Mu-En Liu; Jan-Gowth Chang; Wei-Chiao Chang
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

7.  Role of 1,25-dihydroxy vitamin D3 and parathyroid hormone in urinary calcium excretion in calcium stone formers.

Authors:  Won Tae Kim; Yong-June Kim; Seok Joong Yun; Kyung-Sub Shin; Young Deuk Choi; Sang Cheol Lee; Wun-Jae Kim
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

8.  Genetic polymorphism (rs6776158) in CaSR gene is associated with risk of nephrolithiasis in Chinese population.

Authors:  Hai Zhou; Huaxing Huang; Zebin You; Kamleshsingh Shadhu; Dadhija Ramlagun; Cao Qiang; Pu Li; Lezhong Qi; Yuyong Shen; Ming Zhou; Yuming Chen; Shangchun Fei; Xiaoxiang Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.